Detail akcie Median Techno online

Business Summary: Median Technologies SA is a France-based company that publishes software for the diagnosis and monitoring of cancer patients. The Company develops lesion management solutions (LMS) to objectively measure and track cancerous or suspicious lesions, distribute a standardized oncologic report and centralize the lesion information for multidisciplinary review. The LMS line includes such products as LMS-Lung, a clinical application for the detection, evaluation and follow-up of lesions identified in CT images covering the chest; LMS-Track, a clinical application for the follow-up of oncology patients; and LMS-Liver, a clinical application for the initial evaluation and the follow-up of liver metastases and any other lesions identified in CT images covering the liver. The Company operates one subsidiary, Median Technologies Inc, based in the United States.
Financial Summary: BRIEF: For the six months ended 30 June 2024, Median Technologies SA revenues decreased 3% to EUR10.9M. Net loss increased 23% to EUR12.5M. Revenues reflect United States / Canada segment decrease of 31% to EUR2.6M, China segment decrease of 3% to EUR4.3M. Higher net loss reflects External Costs - Other increase of 14% to EUR9.4M (expense), Interest and financial charges paid increase from EUR662K to EUR1.5M (expense).